For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
In this commentary from Clinical Care Options (CCO), Asim V. Farooq, MD and Joann Kang, MD, provide guidance on monitoring and mitigating ocular toxicities associated with antibody-drug conjugates
Commentary from Dr. Sunil Badve on Ki67 testing for patients with early-stage hormone receptor-positive/HER2-negative breast cancer from the American Society of Clinical Pathology (ASCP) and Clinical Care Options (CCO)
Downloadable summary slideset with key data from the 2021 SABCS Symposium from Clinical Care Options (CCO)
From Clinical Care Options (CCO), experts review key data in genitourinary, gastrointestinal, breast, and lung cancers presented at the ESMO 2021 congress